XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (3,282,092) $ 223,477
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation expenses 46,688 55,458
Amortization of debt issuance costs 2,768 3,923
Non-cash lease expense 143,845 171,935
Deferred income taxes 14,167 96,517
Share-based compensation 888,826
Changes in assets and liabilities:    
Accounts receivable, net (344,779) (570,886)
Prepaid expenses (266,030) (282,508)
Other assets (5,516) (46,074)
Accounts payable and accrued expenses 281,567 128,308
Accrued payroll and other employee costs 175,246 105,120
Due to related party 5,448
Operating lease liabilities (148,125) (176,913)
Finance lease liabilities (288) (689)
Income tax payables (8,756) 5,487
Deferred revenue 596,762 621,707
Other liabilities (193,598) 13,049
Net cash flows provided by (used in) operating activities (2,093,867) 347,911
Cash flows from investing activities:    
Purchases of property and equipment (30,963) (19,894)
Advance and loan provided to related parties (83,798)
Repayment of loan provided to related party 21,508
Net cash flows used in investing activities (9,455) (103,692)
Cash flows from financing activities:    
Proceeds from initial public offering, net of issuance cost 13,602,554
Proceeds from issuance of common shares prior to initial public offering 220,572
Repurchase of common shares (1,336,762)
Payments for finance leases (24,189) (29,561)
Proceeds from long-term debt 258,087
Repayment of long-term debts (469,166) (503,230)
Repayment of insurance premium financing (167,955)
Payments for debt issuance costs (1,030) (1,420)
Payment for mandatorily redeemable financial interest (430,489)
Net cash flows provided by (used in) financing activities 11,651,622 (534,211)
Effect of exchange rate changes (221,960) (149,784)
Net change in cash and cash equivalents 9,326,340 (439,776)
Cash and cash equivalents - beginning of the period 3,136,839 3,058,175
Cash and cash equivalents - end of the period 12,463,179 2,618,399
Supplemental cash flow disclosure:    
Interest paid 28,025 20,635
Income taxes paid 3,013 9,047
Non-cash investing and financing transactions    
Payroll withheld as repayment of loan receivable from employees 12,034 7,240
Expense paid by related party on behalf of the Company 39,679
Liabilities assumed in connection with purchase of property and equipment 9,676
Share repurchase liability settled by issuance of common shares 16
Deferred offering costs recognized against the proceeds from the offering 178,847
Insurance premium financing $ 388,538